Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
South Korea post-marketing safety surveillance of MenACWY-CRM
2017-000166-30Phase 4
- Sponsor
- GSK
- Start
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meningococcal A conjugate vaccine in meningococcal disease, sponsored by GSK. Primary endpoints: Occurrence of local solicited adverse events and Occurrence of systemic solicited adverse events.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-000166-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000166-30.